In this May 4, 2020 photo provided by the University of Maryland School of Medicine, the first patient enrolled in Pfizer’s COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection.
University of Maryland School of Medicine | AP
Pfizer‘s late-stage coronavirus vaccine trial is near complete enrollment with more than 42,000 volunteers, the company announced Tuesday when it released third-quarter earnings.
Nearly 36,000 of the volunteers have already received the second dose, the company said.
This is a developing story. Please check back for updates.
Leave a Reply